DiagnaMed Enters Acquisition Agreement to Acquire Colchester East Natural Hydrogen Project in Nova Scotia

Core Insights - DiagnaMed Holdings Corp. has entered into an acquisition agreement to acquire the Colchester East Natural Hydrogen Project in Nova Scotia, which consists of 30 licenses totaling 2,104 claims [1][2] Strategic Importance - The acquisition positions DiagnaMed within Canada's most active natural hydrogen corridor, attracting attention from major players like Koloma and Rio Tinto, indicating the geological potential of the region [2][5] - The Colchester East Project is strategically located adjacent to significant natural hydrogen properties held by Quebec Innovative Materials Corp. (QIMC) and near recent staking initiatives by Koloma and Rio Tinto [5][6] Geological Indicators - The acquired licenses exhibit geological indicators similar to neighboring discoveries, including fault-controlled migration pathways and proven hydrogen-bearing stratigraphy, providing a solid foundation for exploration [6] Acquisition Terms - DiagnaMed will make a non-refundable cash payment of $10,000 and issue 10,000,000 common shares to the sellers, who will retain a 2.0% royalty on hydrogen or mineral revenues [8][9] - DiagnaMed has the option to repurchase 50% of the sellers' royalty for $2,000,000 [8] Corporate Update - Fabrice Consalvo has joined DiagnaMed's Board of Directors, bringing over 30 years of experience in the global energy sector, which will enhance the company's governance and commercialization strategy [10][11]